Moazzam Shahzad: Haplo-HCT With PTCy Offers a Robust Alternative to MSD-HCT
Moazzam Shahzad, Assistant Professor at University of South Florida and Moffitt Cancer Center, shared a post on X about a recent article he and his colleague co-authored, published in Transplantation and Cellular Therapy, adding:
“Our latest article in Transplantation and Cellular Therapy Journal shows Haplo-HCT with PTCy delivers outcomes comparable to MSD-HCT, supporting its use as a robust alternative when a matched sibling donor is unavailable.”
Al-Ola Abdallah, Associate Professor Of Medicine at University of Kansas Medical Center, Board Member of Kansas Society of Clinical Oncology, shared Moazzam Shahzad‘s post on X:
“I’ve said it before, and I’ll say it again:
Muhammad Umair Mushtaq and Moazzam Shahzad could build an entire cancer center and run all its clinical trials by themselves!
These two are unstoppable machines!”
Title: Outcomes after Matched Sibling Donor versus Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis
Authors: Muhammad Umair Mushtaq, Amir Kasaeian, Tahereh Rostami, Muhammad Kashif Amin, Shayan Forghani, Hediyeh Alemi, Naghmeh Khavandgar, Shah Rukh, Khalid Halahleh, Anurag K. Singh, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Stay updated on all scientific advnaces with Hemostasis Today.
-
Oct 2, 2026, 00:33Marwa Mostafa: Hemoglobinopathies – When Globin Genes Go Wrong
-
Oct 1, 2026, 23:46Behnood Bikdeli: Global Burden of Venous Thromboembolism
-
Oct 1, 2026, 23:46Sthanu Subramanian: Clinical Presentation, Risk Factors, Diagnosis, and Neuroimaging Findings in CVT
-
Oct 1, 2026, 23:45Martha Gulati: Oral MHT Is Associated With Increased Thrombotic Risk
-
Oct 1, 2026, 23:44Priya Sriskandarajah: HEMA-MED Trial Exploring Roginolisib Plus JAK Inhibitors in Myelofibrosis
-
Oct 1, 2026, 23:44Inge Vanhomwegen: Join Our Upcoming Webinar on D-dimer Testing
-
Oct 1, 2026, 23:43Bianca Rocca: Beyond API-CAT – Who Should Continue Anticoagulation, And for How Long?
-
Oct 1, 2026, 23:26Sara Gaafar Ibnauf Suliman: The Changing Role of Bariatric Surgery in the GLP-1 Era
-
Oct 1, 2026, 23:16Ahmed Reda: New Ferritin Cutoffs For Iron Deficiency – Ash 2026